Skip to main content

Welcome

We provide news, expert interviews, and educational resources to help you keep up with the latest developments in oncology

Live webinar

Advances in urothelial cancer treatment and prognosis

This independent medical education meeting has been funded by Astellas.

Panel discussion

An overview of the detection and treatment of ROS1 fusion-positive NSCLC

This content is intended only for healthcare providers and was made possible by educational funding provided by F. Hoffmann-La Roche Ltd.

IN FOCUS | Genitourinary cancers

Box of statins, prescription and a stethoscope

05-12-2022 | Prostate cancer | News

Statins tied to improved survival in men receiving androgen-ablative therapies

Men with advanced prostate cancer may derive a significant survival benefit from the concurrent use of statins alongside androgen-ablative therapies, suggest the Canadian authors of a systematic review and meta-analysis.

IN FOCUS | Lung & thoracic cancers

DNA mutation

28-10-2022 | Non-small-cell lung cancer | News

Real-world study adds support for osimertinib for uncommon EGFR mutations

Osimertinib elicits high rates of systemic and intracranial response in people with advanced non-small-cell lung cancer harboring uncommon EGFR mutations, say the authors of the real-world UNICORN study.

IN FOCUS | Breast cancer

Woman taking medication

08-12-2022 | SABCS 2022 | Conference coverage | News

First-line ribociclib plus ET RIGHT Choice for aggressive advanced breast cancer

Ribociclib plus endocrine therapy is associated with a significant progression-free survival benefit relative to combination chemotherapy in treatment-naïve patients with hormone receptor-positive, HER2-negative, advanced breast cancer with aggressive features, suggest trial data.

IN FOCUS | COVID-19 & cancer

Antibodies attacking SARS-CoV-2 virus, the conceptual 3D illustration for COVID-19 treatment, diagnosis and prevention

10-01-2023 | COVID-19 | News

Antibody testing may identify cancer patients at increased risk of COVID-19 breakthrough infections

A Canadian population-based study has confirmed that people with cancer have an increased risk of breakthrough COVID-19 infection after vaccination, while UK research points to the feasibility of SARS-CoV-2 antibody testing to identify those with the lowest level of vaccine-derived protection.

Stay informed with Medicine Matters

Get the latest developments in breast, lung, & GU cancers delivered straight to your inbox